11-17559132-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001292063.2(OTOG):āc.1184A>Cā(p.Gln395Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,541,236 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.1184A>C | p.Gln395Pro | missense_variant | 11/56 | ENST00000399397.6 | |
OTOG | NM_001277269.2 | c.1220A>C | p.Gln407Pro | missense_variant | 10/55 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.1184A>C | p.Gln395Pro | missense_variant | 11/56 | 5 | NM_001292063.2 | P2 | |
OTOG | ENST00000399391.7 | c.1220A>C | p.Gln407Pro | missense_variant | 10/55 | 5 | A2 | ||
OTOG | ENST00000498332.5 | n.1090A>C | non_coding_transcript_exon_variant | 10/16 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000683 AC: 95AN: 139058Hom.: 1 AF XY: 0.000423 AC XY: 32AN XY: 75676
GnomAD4 exome AF: 0.000107 AC: 149AN: 1388910Hom.: 1 Cov.: 31 AF XY: 0.0000817 AC XY: 56AN XY: 685458
GnomAD4 genome AF: 0.000197 AC: 30AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74492
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 08, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 21, 2016 | The p.Gln407Pro variant in OTOG has not been previously reported in individuals with hearing loss. Data from large population studies are insufficient to assess the frequency of this variant. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Gln407Pro variant is uncertain. - |
Autosomal recessive nonsyndromic hearing loss 18B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
OTOG-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 05, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at